Specialization
Focus of research
Regulatory science, rare diseases, orphan drugs
-
Reliable business case for repurposing of existing medicines requires key changes in government policies
de Visser, S. J., van den Berg, S., Mosterd, A. & Lo, D. C., 1 Sept 2024, In: Drug Discovery Today. 29, 9, 104096.Research output: Contribution to journal › Editorial › Academic › peer-review
-
Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public–private partnerships
Rosenberg, N., Stolwijk, N. N., van den Berg, S., Heus, J. J., van der Wel, V., van Gelder, T., Bosch, A. M., de Visser, S. J. & Hollak, C. E. M., Sept 2023, In: Journal of inherited metabolic disease. 46, 5, p. 806-816 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Bereiding van geneesmiddelen in de apotheek
Translated title of the contribution :Medicine compounding in the pharmacy Research output: Contribution to journal › Article › Professional
- All publications